Literature DB >> 34380736

RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity.

Pau Castel1, Srisathiyanarayanan Dharmaiah2, Matthew J Sale1, Simon Messing2, Gabrielle Rizzuto3, Antonio Cuevas-Navarro1, Alice Cheng1, Michael J Trnka4, Anatoly Urisman3, Dominic Esposito2, Dhirendra K Simanshu5, Frank McCormick6.   

Abstract

RAS proteins are molecular switches that interact with effector proteins when bound to guanosine triphosphate, stimulating downstream signaling in response to multiple stimuli. Although several canonical downstream effectors have been extensively studied and tested as potential targets for RAS-driven cancers, many of these remain poorly characterized. In this study, we undertook a biochemical and structural approach to further study the role of Sin1 as a RAS effector. Sin1 interacted predominantly with KRAS isoform 4A in cells through an atypical RAS-binding domain that we have characterized by X-ray crystallography. Despite the essential role of Sin1 in the assembly and activity of mTORC2, we find that the interaction with RAS is not required for these functions. Cells and mice expressing a mutant of Sin1 that is unable to bind RAS are proficient for activation and assembly of mTORC2. Our results suggest that Sin1 is a bona fide RAS effector that regulates downstream signaling in an mTORC2-independent manner.

Entities:  

Keywords:  KRAS; RAS; RBD; Sin1; mTORC2

Mesh:

Substances:

Year:  2021        PMID: 34380736      PMCID: PMC8379911          DOI: 10.1073/pnas.2103261118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  76 in total

1.  Molecular Basis of the Rapamycin Insensitivity of Target Of Rapamycin Complex 2.

Authors:  Christl Gaubitz; Taiana M Oliveira; Manoel Prouteau; Alexander Leitner; Manikandan Karuppasamy; Georgia Konstantinidou; Delphine Rispal; Sandra Eltschinger; Graham C Robinson; Stéphane Thore; Ruedi Aebersold; Christiane Schaffitzel; Robbie Loewith
Journal:  Mol Cell       Date:  2015-05-28       Impact factor: 17.970

2.  Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.

Authors:  Robbie Loewith; Estela Jacinto; Stephan Wullschleger; Anja Lorberg; José L Crespo; Débora Bonenfant; Wolfgang Oppliger; Paul Jenoe; Michael N Hall
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

3.  Computational Modeling Reveals that Signaling Lipids Modulate the Orientation of K-Ras4A at the Membrane Reflecting Protein Topology.

Authors:  Zhen-Lu Li; Matthias Buck
Journal:  Structure       Date:  2017-03-09       Impact factor: 5.006

4.  Isolation of the mTOR complexes by affinity purification.

Authors:  Dos D Sarbassov; Olga Bulgakova; Rakhmet I Bersimbaev; Tattym Shaiken
Journal:  Methods Mol Biol       Date:  2012

5.  SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.

Authors:  Estela Jacinto; Valeria Facchinetti; Dou Liu; Nelyn Soto; Shiniu Wei; Sung Yun Jung; Qiaojia Huang; Jun Qin; Bing Su
Journal:  Cell       Date:  2006-09-07       Impact factor: 41.582

6.  Human Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling.

Authors:  Wayne A Schroder; Marion Buck; Nicole Cloonan; John F Hancock; Andreas Suhrbier; Tom Sculley; Gillian Bushell
Journal:  Cell Signal       Date:  2007-01-20       Impact factor: 4.315

Review 7.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

8.  The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C.

Authors:  Valeria Facchinetti; Weiming Ouyang; Hua Wei; Nelyn Soto; Adam Lazorchak; Christine Gould; Carolyn Lowry; Alexandra C Newton; Yuxin Mao; Robert Q Miao; William C Sessa; Jun Qin; Pumin Zhang; Bing Su; Estela Jacinto
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

9.  Cryo-EM structure of Saccharomyces cerevisiae target of rapamycin complex 2.

Authors:  Manikandan Karuppasamy; Beata Kusmider; Taiana M Oliveira; Christl Gaubitz; Manoel Prouteau; Robbie Loewith; Christiane Schaffitzel
Journal:  Nat Commun       Date:  2017-11-23       Impact factor: 14.919

10.  Structures of N-terminally processed KRAS provide insight into the role of N-acetylation.

Authors:  Srisathiyanarayanan Dharmaiah; Timothy H Tran; Simon Messing; Constance Agamasu; William K Gillette; Wupeng Yan; Timothy Waybright; Patrick Alexander; Dominic Esposito; Dwight V Nissley; Frank McCormick; Andrew G Stephen; Dhirendra K Simanshu
Journal:  Sci Rep       Date:  2019-07-19       Impact factor: 4.379

View more
  4 in total

1.  Regulation of GTPase function by autophosphorylation.

Authors:  Christian W Johnson; Hyuk-Soo Seo; Elizabeth M Terrell; Moon-Hee Yang; Fenneke KleinJan; Teklab Gebregiworgis; Genevieve M C Gasmi-Seabrook; Ezekiel A Geffken; Jimit Lakhani; Kijun Song; Puspalata Bashyal; Olesja Popow; Joao A Paulo; Andrea Liu; Carla Mattos; Christopher B Marshall; Mitsuhiko Ikura; Deborah K Morrison; Sirano Dhe-Paganon; Kevin M Haigis
Journal:  Mol Cell       Date:  2022-02-23       Impact factor: 17.970

2.  TOR complex 2 is a master regulator of plasma membrane homeostasis.

Authors:  Jeremy Thorner
Journal:  Biochem J       Date:  2022-09-30       Impact factor: 3.766

3.  Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention.

Authors:  Christian Johnson; Deborah L Burkhart; Kevin M Haigis
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 38.272

4.  Structural insights into Ras regulation by SIN1.

Authors:  Yuyuan Zheng; Lei Ding; Xianhui Meng; Meg Potter; Alison L Kearney; Jie Zhang; Jie Sun; David E James; Guang Yang; Chun Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-06       Impact factor: 12.779

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.